Consideration of Acceptable Market Name Change for Certain Rockfish (Sebastes spp.); Request for Information
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The U.S. Food and Drug Administration (FDA) has issued a notice requesting public data and information to evaluate a potential update to the acceptable market names for 18 specific rockfish species in the genus Sebastes. These species include Sebastes alutus (Pacific ocean perch), Sebastes borealis (shortraker rockfish), and others like Sebastes melanops (black rockfish) and Sebastes pinniger (canary rockfish). The goal is to make an evidence-based decision that considers food safety, regulatory clarity for labeling and trade, and interests of the fishing and seafood industry. Currently, these fish may be marketed under various common names that could lead to confusion or mislabeling risks. The FDA seeks evidence on whether changing to standardized 'rockfish' or similar acceptable market names would improve consumer protection, prevent economic fraud, and align with scientific taxonomy without harming market viability. Stakeholders are asked to submit data on current naming practices, safety profiles, harvest locations, and economic impacts by a deadline implied in the Federal Register process. This request does not propose immediate changes but initiates a comment period to gather facts. It balances public health assurances—such as allergen labeling and species-specific hazards—with industry needs for flexible, recognizable market names that support commerce in the multi-billion-dollar U.S. seafood sector.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- FDA requests data on 18 specific Sebastes species for market name updates
- Evaluation balances food safety, regulatory clarity, and industry interests
- Potential shift to standardized 'rockfish' acceptable market names
+ 3 more changes with Pro
Obligations
What this law requires
Submit data and information on current naming practices for the 18 specified Sebastes spp. rockfish species to the FDA by the Federal Register comment deadline
Provide evidence on safety profiles (including species-specific hazards and allergen information) for each of the 18 Sebastes species to support FDA's market name determination
Submit documentation of harvest locations and geographic sourcing information for the 18 Sebastes species rockfish
Provide economic impact data demonstrating how proposed acceptable market name changes would affect market viability and commercial operations
Document current labeling and marketing practices used for the 18 Sebastes species to identify mislabeling risks and consumer confusion